Management tracks: Abeona, INKEF, Incyte

Abeona Therapeutics Inc. (NASDAQ:ABEO) terminated Carsten Thiel for personal misconduct towards colleagues, less than eight months after hiring him as CEO. The rare genetic disease company named Head of R&D and CMO João Siffert interim CEO while a permanent successor is sought.

Prior to Abeona, Thiel served as CCO of Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) until his departure in 2017, one of several from that company amid an investigation into Alexion’s sales practices for Soliris eculizumab (see “Alexion Shuffles Management Again”)...